223 related articles for article (PubMed ID: 31092478)
1. Iatrogenic Hyperinsulinemia, Not Hyperglycemia, Drives Insulin Resistance in Type 1 Diabetes as Revealed by Comparison With GCK-MODY (MODY2).
Gregory JM; Smith TJ; Slaughter JC; Mason HR; Hughey CC; Smith MS; Kandasamy B; Greeley SAW; Philipson LH; Naylor RN; Letourneau LR; Abumrad NN; Cherrington AD; Moore DJ
Diabetes; 2019 Aug; 68(8):1565-1576. PubMed ID: 31092478
[TBL] [Abstract][Full Text] [Related]
2. Metabolite profiling reveals normal metabolic control in carriers of mutations in the glucokinase gene (MODY2).
Spégel P; Ekholm E; Tuomi T; Groop L; Mulder H; Filipsson K
Diabetes; 2013 Feb; 62(2):653-61. PubMed ID: 23139355
[TBL] [Abstract][Full Text] [Related]
3. Genetic and clinical characterisation of maturity-onset diabetes of the young in Spanish families.
Costa A; Bescós M; Velho G; Chêvre J; Vidal J; Sesmilo G; Bellanné-Chantelot C; Froguel P; Casamitjana R; Rivera-Fillat F; Gomis R; Conget I
Eur J Endocrinol; 2000 Apr; 142(4):380-6. PubMed ID: 10754480
[TBL] [Abstract][Full Text] [Related]
4. Recognition and Management of Individuals With Hyperglycemia Because of a Heterozygous Glucokinase Mutation.
Chakera AJ; Steele AM; Gloyn AL; Shepherd MH; Shields B; Ellard S; Hattersley AT
Diabetes Care; 2015 Jul; 38(7):1383-92. PubMed ID: 26106223
[TBL] [Abstract][Full Text] [Related]
5. The clinical management of hyperglycemia in pregnancy complicated by maturity-onset diabetes of the young.
Bacon S; Schmid J; McCarthy A; Edwards J; Fleming A; Kinsley B; Firth R; Byrne B; Gavin C; Byrne MM
Am J Obstet Gynecol; 2015 Aug; 213(2):236.e1-7. PubMed ID: 25935773
[TBL] [Abstract][Full Text] [Related]
6. A review of maturity onset diabetes of the young (MODY) and challenges in the management of glucokinase-MODY.
Bishay RH; Greenfield JR
Med J Aust; 2016 Nov; 205(10):480-485. PubMed ID: 27852188
[TBL] [Abstract][Full Text] [Related]
7. Insights into pathogenesis of five novel GCK mutations identified in Chinese MODY patients.
Liu L; Liu Y; Ge X; Liu X; Chen C; Wang Y; Li M; Yin J; Zhang J; Chen Y; Zhang R; Jiang Y; Zhao W; Yang D; Zheng T; Lu M; Zhuang L; Jiang M
Metabolism; 2018 Dec; 89():8-17. PubMed ID: 30257192
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic screening of MODY2/GCK mutations in the Norwegian MODY Registry.
Sagen JV; Bjørkhaug L; Molnes J; Raeder H; Grevle L; Søvik O; Molven A; Njølstad PR
Pediatr Diabetes; 2008 Oct; 9(5):442-9. PubMed ID: 18399931
[TBL] [Abstract][Full Text] [Related]
9. Incretin hormones and maturity onset diabetes of the young--pathophysiological implications and anti-diabetic treatment potential.
Østoft SH
Dan Med J; 2015 Sep; 62(9):. PubMed ID: 26324089
[TBL] [Abstract][Full Text] [Related]
10. Hyperinsulinemia prevents prolonged hyperglycemia after intense exercise in insulin-dependent diabetic subjects.
Sigal RJ; Purdon C; Fisher SJ; Halter JB; Vranic M; Marliss EB
J Clin Endocrinol Metab; 1994 Oct; 79(4):1049-57. PubMed ID: 7962273
[TBL] [Abstract][Full Text] [Related]
11. Caudal regression syndrome in a fetus of a glucokinase-maturity-onset diabetes of the young pregnancy.
Taylor RAM; Mackie A; Mogra R; Pinner J; Rajendran S; Ross GP
Diabet Med; 2019 Feb; 36(2):252-255. PubMed ID: 30362177
[TBL] [Abstract][Full Text] [Related]
12. Phenotype Heterogeneity in Glucokinase-Maturity-Onset Diabetes of the Young (GCK-MODY) Patients.
Wędrychowicz A; Tobór E; Wilk M; Ziółkowska-Ledwith E; Rams A; Wzorek K; Sabal B; Stelmach M; Starzyk JB
J Clin Res Pediatr Endocrinol; 2017 Sep; 9(3):246-252. PubMed ID: 28663157
[TBL] [Abstract][Full Text] [Related]
13. Incidental mild hyperglycemia in children: two MODY 2 families identified in Brazilian subjects.
Caetano LA; Jorge AA; Malaquias AC; Trarbach EB; Queiroz MS; Nery M; Teles MG
Arq Bras Endocrinol Metabol; 2012 Nov; 56(8):519-24. PubMed ID: 23295292
[TBL] [Abstract][Full Text] [Related]
14. Management and pregnancy outcomes of women with GCK-MODY enrolled in the US Monogenic Diabetes Registry.
Dickens LT; Letourneau LR; Sanyoura M; Greeley SAW; Philipson LH; Naylor RN
Acta Diabetol; 2019 Apr; 56(4):405-411. PubMed ID: 30535721
[TBL] [Abstract][Full Text] [Related]
15. beta-cell genes and diabetes: quantitative and qualitative differences in the pathophysiology of hepatic nuclear factor-1alpha and glucokinase mutations.
Pearson ER; Velho G; Clark P; Stride A; Shepherd M; Frayling TM; Bulman MP; Ellard S; Froguel P; Hattersley AT
Diabetes; 2001 Feb; 50 Suppl 1():S101-7. PubMed ID: 11272165
[TBL] [Abstract][Full Text] [Related]
16. Plasma follistatin is elevated in patients with type 2 diabetes: relationship to hyperglycemia, hyperinsulinemia, and systemic low-grade inflammation.
Hansen J; Rinnov A; Krogh-Madsen R; Fischer CP; Andreasen AS; Berg RM; Møller K; Pedersen BK; Plomgaard P
Diabetes Metab Res Rev; 2013 Sep; 29(6):463-72. PubMed ID: 23564759
[TBL] [Abstract][Full Text] [Related]
17. HDL cholesterol as a diagnostic tool for clinical differentiation of GCK-MODY from HNF1A-MODY and type 1 diabetes in children and young adults.
Fendler W; Borowiec M; Antosik K; Szadkowska A; Deja G; Jarosz-Chobot P; Mysliwiec M; Wyka K; Pietrzak I; Skupien J; Malecki MT; Mlynarski W
Clin Endocrinol (Oxf); 2011 Sep; 75(3):321-7. PubMed ID: 21521320
[TBL] [Abstract][Full Text] [Related]
18. Maturity onset diabetes of young type 2 due to a novel de novo GKC mutation.
Afonso P; Ferraria N; Carvalho A; Castro SV
Arq Bras Endocrinol Metabol; 2014 Oct; 58(7):772-5. PubMed ID: 25372588
[TBL] [Abstract][Full Text] [Related]
19. Glucokinase (GCK) mutations in hyper- and hypoglycemia: maturity-onset diabetes of the young, permanent neonatal diabetes, and hyperinsulinemia of infancy.
Gloyn AL
Hum Mutat; 2003 Nov; 22(5):353-62. PubMed ID: 14517946
[TBL] [Abstract][Full Text] [Related]
20. Hyperglycemia stimulates coagulation, whereas hyperinsulinemia impairs fibrinolysis in healthy humans.
Stegenga ME; van der Crabben SN; Levi M; de Vos AF; Tanck MW; Sauerwein HP; van der Poll T
Diabetes; 2006 Jun; 55(6):1807-12. PubMed ID: 16731846
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]